Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment
Journal of Translational Medicine · 07.10.2024 · 22 (1)
DOI: 10.1186/s12967-024-05652-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Medicine, online erschienen am 07.10.2024. Verfasst von Jun Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Arginine, Tumor-Associated Macrophages. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, The Key Research and Development Project of Department of Science and Technology of Hubei, The China Postdoctoral Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Arginase is abundantly expressed in colorectal cancer and disrupts arginine metabolism, promoting the formation of an immunosuppressive tumor microenvironment. This significant factor contributes to the insensitivity of colorectal cancer to immunotherapy. Tumor-associated macrophages (TAMs) are major immune cells in this environment, and aberrant arginine metabolism in tumor tissues induces TAM polarization toward M2-like macrophages. The natural compound piceatannol 3'-O-glucoside inhibits arginase activity and activates nitric oxide synthase, thereby reducing M2-like macrophages while promoting M1-like macrophage polarization. METHODS: The natural compounds piceatannol 3'-O-glucoside and indocyanine green were encapsulated within microparticles derived from tumor cells, termed PG/ICG@MPs. The enhanced cancer therapeutic effect of PG/ICG@MP was assessed both in vitro and in vivo. RESULTS: PG/ICG@MP precisely targets the tumor site, with piceatannol 3'-O-glucoside concurrently inhibiting arginase activity and activating nitric oxide synthase. This process promotes increased endogenous nitric oxide production through arginine metabolism. The combined actions of nitric oxide and piceatannol 3'-O-glucoside facilitate the repolarization of tumor-associated macrophages toward the M1 phenotype. Furthermore, the increase in endogenous nitric oxide levels, in conjunction with the photodynamic effect induced by indocyanine green, increases the quantity of reactive oxygen species. This dual effect not only enhances tumor immunity but also exerts remarkable inhibitory effects on tumors. CONCLUSION: Our research results demonstrate the excellent tumor-targeting effect of PG/ICG@MPs. By modulating arginine metabolism to improve the tumor immune microenvironment, we provide an effective approach with clinical translational significance for combined cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. yinghaocao@hust.edu.cn.
- Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore. yinghaocao@hust.edu.cn.
- Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. caikailin@hust.edu.cn.
Förderung
- National Natural Science Foundation of China
- The Key Research and Development Project of Department of Science and Technology of Hubei
- The China Postdoctoral Science Foundation
Zitieren
APA
Wang, J., Deng, S., Cheng, D., Gu, J., Qin, L., Mao, F., Xue, Y., Jiang, Z., Chen, M., Zou, F., Huang, N., Cao, Y., & Cai, K. (2024). Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05652-3
Vancouver
Wang J, Deng S, Cheng D, Gu J, Qin L, Mao F, et al. Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment. Journal of Translational Medicine. 2024;22(1). doi:10.1186/s12967-024-05652-3
BibTeX
@article{Wang2024,
author = {Wang, Jun and Deng, Shenghe and Cheng, Denglong and Gu, Junnan and Qin, Le and Mao, Fuwei and Xue, Yifan and Jiang, Zhenxin and Chen, Mian and Zou, Falong and Huang, Ning and Cao, Yinghao and Cai, Kailin},
title = {Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment},
journal = {Journal of Translational Medicine},
year = {2024},
volume = {22},
number = {1},
doi = {10.1186/s12967-024-05652-3}
}
EUVIMED